• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study.

作者信息

David Clémence, Costedoat-Chalumeau Nathalie, Belhadi Drifa, Laouénan Cedric, Boutten Anne, Chezel Julie, Rouzaud Diane, Dehoux Monique, Guern Véronique Le, Mathian Alexis, Chaves Sébastien de Almeida, Duhaut Pierre, Fain Olivier, Galicier Lionel, Ghillani-Dalbin Pascale, Kahn Jean Emmanuel, Morel Nathalie, Perard Laurent, Pha Micheline, Sarrot-Reynauld Francoise, Aumaitre Olivier, Chasset François, Limal Nicolas, Desmurs-Clavel Helene, Ackermann Felix, Amoura Zahir, Papo Thomas, Sacre Karim

机构信息

Département de Médecine Interne, Hôpital Bichat, Assistance Publique Hôpitaux de Paris (APHP), Institut national de la santé et de la recherche médicale (INSERM) U1149, Université de Paris, Paris, France.

APHP, Hôpital Cochin, Département de Médecine Interne, Centre de Reference Maladies Auto-immunes et Systémiques Rares, Université de Paris, CRESS, INSERM, INRA, Paris, France.

出版信息

J Intern Med. 2022 Sep;292(3):536-539. doi: 10.1111/joim.13490. Epub 2022 Apr 10.

DOI:10.1111/joim.13490
PMID:35373869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9542031/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b8/9542031/37b8ac33ecf0/JOIM-292-536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b8/9542031/37b8ac33ecf0/JOIM-292-536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b8/9542031/37b8ac33ecf0/JOIM-292-536-g001.jpg

相似文献

1
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study.可溶性CD163与系统性红斑狼疮患者的心血管事件发生：一项观察性队列研究。
J Intern Med. 2022 Sep;292(3):536-539. doi: 10.1111/joim.13490. Epub 2022 Apr 10.
2
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.可溶性 CD163 是系统性红斑狼疮患者发生动脉粥样硬化加速的生物标志物，这些患者的心血管疾病发病风险看似较低。
Scand J Rheumatol. 2020 Jan;49(1):33-37. doi: 10.1080/03009742.2019.1614213. Epub 2019 Jun 4.
3
Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.可溶性 CD163 作为与系统性红斑狼疮相关的巨噬细胞活化综合征的生物标志物的有用性。
Lupus. 2019 Jul;28(8):986-994. doi: 10.1177/0961203319860201.
4
Palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus: possible involvement of CD163 M2 macrophages in two cases, and a review of published works.与系统性红斑狼疮相关的栅栏状中性粒细胞和肉芽肿性皮炎：两例病例中CD163 M2巨噬细胞可能受累，并对已发表文献进行综述
Lupus. 2018 Dec;27(14):2220-2227. doi: 10.1177/0961203318809892. Epub 2018 Oct 30.
5
Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.尿可溶性 CD163：狼疮肾炎活动的新型无创生物标志物。
J Am Soc Nephrol. 2020 Jun;31(6):1335-1347. doi: 10.1681/ASN.2019121285. Epub 2020 Apr 16.
6
A Rare Case of Acute Fibrinous and Organizing Pneumonia Associated with Systemic Lupus Erythematosus and Autoimmune-associated Hemophagocytic Syndrome: The Involvement of CD163-positive Macrophages.一种罕见的系统性红斑狼疮和自身免疫性噬血细胞综合征相关的急性纤维蛋白性和机化性肺炎：CD163 阳性巨噬细胞的参与。
Intern Med. 2022 Feb 15;61(4):559-565. doi: 10.2169/internalmedicine.7184-21. Epub 2021 Aug 24.
7
CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.CD163 的表达在系统性红斑狼疮患者的受累皮肤和血清中增加。
Eur J Dermatol. 2012 Jul-Aug;22(4):512-7. doi: 10.1684/ejd.2012.1756.
8
Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.巨噬细胞活化综合征作为儿童风湿性疾病的首发表现
J Pediatr. 2006 May;148(5):683-6. doi: 10.1016/j.jpeds.2005.12.070.
9
Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis.尿可溶性 CD163 是狼疮肾炎诊断和评估的有前途的生物标志物。
Front Immunol. 2022 Jul 14;13:935700. doi: 10.3389/fimmu.2022.935700. eCollection 2022.
10
Epidemiology of cardiovascular disease in systemic lupus erythematosus.系统性红斑狼疮中心血管疾病的流行病学
Lupus. 2000;9(3):166-9. doi: 10.1191/096120300678828208.

引用本文的文献

1
Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.非酒精性脂肪性肝病与心力衰竭：一项全面的生物信息学和孟德尔随机化分析
ESC Heart Fail. 2024 Dec;11(6):4185-4200. doi: 10.1002/ehf2.15019. Epub 2024 Aug 14.

本文引用的文献

1
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review.可溶性 CD163，一种新型巨噬细胞活化标志物，与 2 型糖尿病及其潜在生理紊乱的关联：系统评价。
Obes Rev. 2021 Sep;22(9):e13257. doi: 10.1111/obr.13257. Epub 2021 Apr 28.
2
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).高敏血清心肌肌钙蛋白 T 与系统性红斑狼疮患者的心血管事件（TROPOPLUS 研究）。
Rheumatology (Oxford). 2021 Mar 2;60(3):1210-1215. doi: 10.1093/rheumatology/keaa434.
3
Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
BAFF 中和作用对系统性红斑狼疮相关动脉粥样硬化的影响。
Arthritis Rheumatol. 2021 Feb;73(2):255-264. doi: 10.1002/art.41485. Epub 2020 Dec 15.
4
Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.尿可溶性 CD163：狼疮肾炎活动的新型无创生物标志物。
J Am Soc Nephrol. 2020 Jun;31(6):1335-1347. doi: 10.1681/ASN.2019121285. Epub 2020 Apr 16.
5
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.可溶性 CD163 是系统性红斑狼疮患者发生动脉粥样硬化加速的生物标志物，这些患者的心血管疾病发病风险看似较低。
Scand J Rheumatol. 2020 Jan;49(1):33-37. doi: 10.1080/03009742.2019.1614213. Epub 2019 Jun 4.
6
CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.CD163+ 巨噬细胞促进动脉粥样硬化中的血管生成和血管通透性，并伴有炎症。
J Clin Invest. 2018 Mar 1;128(3):1106-1124. doi: 10.1172/JCI93025. Epub 2018 Feb 19.
7
Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study.超重是心血管疾病低风险的系统性红斑狼疮患者动脉粥样硬化的主要促成因素：一项横断面对照研究。
Medicine (Baltimore). 2015 Dec;94(48):e2177. doi: 10.1097/MD.0000000000002177.
8
CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus.CD4+CXCR3+T 细胞和浆细胞样树突状细胞驱动与系统性红斑狼疮相关的动脉粥样硬化加速。
J Autoimmun. 2015 Sep;63:59-67. doi: 10.1016/j.jaut.2015.07.001. Epub 2015 Jul 14.
9
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).羟氯喹治疗红斑狼疮的多中心对照试验（PLUS 研究）结果
Ann Rheum Dis. 2013 Nov;72(11):1786-92. doi: 10.1136/annrheumdis-2012-202322. Epub 2012 Nov 10.
10
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.传统的弗雷明汉姆风险因素无法完全解释系统性红斑狼疮中加速的动脉粥样硬化。
Arthritis Rheum. 2001 Oct;44(10):2331-7. doi: 10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i.